Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03601897
Title A Safety, Tolerability and PK Study of Rebastinib in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35233 United States Details
University of Colorado Denver- Anschutz Medical Center Aurora Colorado 80045 United States Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
The University of Kansas Clinical Research Center Kansas City Kansas 66160 United States Details
Dana-Farber Boston Massachusetts 02215 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
Northwell Health/Monter Cancer Center Lake Success New York 11042 United States Details
Ohio State University Wexner Medical Center Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Women & Infants Hospital Providence Rhode Island 02905 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Oncology Consultants- Texas Medical Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field